Ken Griffin Immatics N.V. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Immatics N.V. stock. As of the latest transaction made, Citadel Advisors LLC holds 85,300 shares of IMTX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,300
Previous 90,000
5.22%
Holding current value
$1.04 Million
Previous $945,000
4.87%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IMTX
# of Institutions
99Shares Held
76.6MCall Options Held
571KPut Options Held
210K-
Rtw Investments, LP New York, NY10MShares$122 Million1.94% of portfolio
-
Wellington Management Group LLP Boston, MA9.54MShares$116 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$98.3 Million2.72% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.43MShares$90.4 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$78.4 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $927M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...